• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Infinity Pharmaceuticals, Inc. - Common Stock (NQ:INFI)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 13, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.0395 (60)
Ask (Size) 0.0400 (90)
Prev. Close 0.0447
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding 88,719,539
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INFI DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action – INFI
October 16, 2023
From The Rosen Law Firm, P.A.
Via Business Wire
INFI DEADLINE TOMORROW: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI
October 15, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit

Performance

More News

Read More
INFINITY DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
October 13, 2023
From Bragar Eagel & Squire, P.C.
Via Business Wire
INFI DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI
October 11, 2023
Via NewMediaWire
Topics Lawsuit
INFI DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI
October 10, 2023
Via NewMediaWire
Topics Lawsuit
NASDAQ:INFI Investor Alert: Deadline on October 16, 2023 in Lawsuit Against Infinity Pharmaceuticals, Inc. Coming Up
October 09, 2023
Via SBWire
Topics Lawsuit
INFINITY ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Infinity Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
October 08, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
INFI DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 16 Deadline in Securities Class Action - INFI
October 07, 2023
Via NewMediaWire
Topics Lawsuit
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
October 03, 2023
Via TheNewswire.com
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Applied Digital, Infinity, and Shift4 and Encourages Investors to Contact the Firm
October 02, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
October 02, 2023
Via NewMediaWire
Topics Lawsuit
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - INFI
October 01, 2023
Via TheNewswire.com
Topics Lawsuit
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - INFI
October 01, 2023
Via NewMediaWire
Topics Lawsuit
ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INFI
September 28, 2023
From The Rosen Law Firm PA
Via GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Live Nation, Applied Digital, and Infinity and Encourages Investors to Contact the Firm
September 27, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
September 24, 2023
Via TheNewswire.com
Topics Lawsuit
ROSEN, LEADING INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
September 24, 2023
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm
September 22, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
September 21, 2023
Via TheNewswire.com
Topics Lawsuit
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - INFI
September 21, 2023
Via NewMediaWire
Topics Lawsuit
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Infinity, Shift4, and Comerica and Encourages Investors to Contact the Firm
September 17, 2023
From Bragar Eagel & Squire
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – INFI
September 17, 2023
From The Rosen Law Firm PA
Via GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI
September 16, 2023
Via TheNewswire.com
Topics Lawsuit
ROSEN, A LEADING LAW FIRM, Encourages Infinity Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INFI
September 16, 2023
Via NewMediaWire
Topics Lawsuit
12 Health Care Stocks Moving In Wednesday's After-Market Session
September 13, 2023
Via Benzinga

Frequently Asked Questions

Is Infinity Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Infinity Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Infinity Pharmaceuticals, Inc. - Common Stock trade on?
Infinity Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Infinity Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Infinity Pharmaceuticals, Inc. - Common Stock is INFI on the Nasdaq Stock Market
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap